Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
Addisonian pernicious anaemia.
Prophylaxis and treatment of other macrocytic anaemias associated with vitamin B12 deficiency.
Tobacco amblyopia and Leber’s optic atrophy.
Intramuscular.
Initially: 250 to 1000mcg intramuscularly on alternate days for one to two weeks, then 250mcg weekly until the blood count is normal.
Maintenance: 1000mcg every two to three months.
Initially: 1000mcg on alternate days as long as improvement is occurring.
Maintenance: 1000mcg every two months.
1000mcg every two to three months.
Initially: 1000mcg or more daily by intramuscular injection for two weeks. Then twice weekly as long as improvement is occurring.
Maintenance: 1000mcg monthly.
Treatment is unlikely to be needed in cases of overdosage.
36 months.
Protect from light. Do not store above 25°C.
1ml clear, one-point cut (OPC) glass Type 1 Ph Eur ampoules packed in cartons of 5 ampoules.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.